Literature DB >> 10623917

Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments.

M Mazumdar1, J R Glassman.   

Abstract

Categorizing prognostic variables is essential for their use in clinical decision-making. Often a single cutpoint that stratifies patients into high-risk and low-risk categories is sought. These categories may be used for making treatment recommendations, determining study eligibility, or to control for varying patient prognoses in the design of a clinical trial. Methods used to categorize variables include: biological determination (most desirable but often unavailable); arbitrary selection of a cutpoint at the median value; graphical examination of the data for a threshold effect; and exploration of all observed values for the one which best separates the risk groups according to a chi-squared test. The last method, called the minimum p-value approach, involves multiple testing which inflates the type I error rates. Several methods for adjusting the inflated p-values have been proposed but remain infrequently used. Exploratory methods for categorization and the minimum p-value approach with its various p-value corrections are reviewed, and code for their easy implementation is provided. The combined use of these methods is recommended, and demonstrated in the context of two cancer-related examples which highlight a variety of the issues involved in the categorization of prognostic variables. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623917     DOI: 10.1002/(sici)1097-0258(20000115)19:1<113::aid-sim245>3.0.co;2-o

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  96 in total

1.  Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma.

Authors:  Ya-Hui Huang; Kwang-Huei Lin; Hua-Chien Chen; Ming-Ling Chang; Chao-Wei Hsu; Ming-Wei Lai; Tse-Ching Chen; Wei-Chen Lee; Yi-Hsin Tseng; Chau-Ting Yeh
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

Review 2.  A Review of Cutoffs for Nutritional Biomarkers.

Authors:  Ramkripa Raghavan; Fayrouz Sakr Ashour; Regan Bailey
Journal:  Adv Nutr       Date:  2016-01-15       Impact factor: 8.701

3.  Tumor Heterogeneity Correlates with Less Immune Response and Worse Survival in Breast Cancer Patients.

Authors:  Kerry-Ann McDonald; Tsutomu Kawaguchi; Qianya Qi; Xuan Peng; Mariko Asaoka; Jessica Young; Mateusz Opyrchal; Li Yan; Santosh Patnaik; Eigo Otsuji; Kazuaki Takabe
Journal:  Ann Surg Oncol       Date:  2019-04-08       Impact factor: 5.344

4.  Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes.

Authors:  Anita Kumar; Irene A Burger; Zhigang Zhang; Esther N Drill; Jocelyn C Migliacci; Andrea Ng; Ann LaCasce; Darci Wall; Thomas E Witzig; Kay Ristow; Joachim Yahalom; Craig H Moskowitz; Andrew D Zelenetz
Journal:  Haematologica       Date:  2016-07-06       Impact factor: 9.941

5.  The type of patients who would benefit from anti-androgen withdrawal therapy: could it be performed safely for aggressive prostate cancer?

Authors:  Kazuhiro Matsumoto; Nobuyuki Tanaka; Nozomi Hayakawa; Taisuke Ezaki; Kenjiro Suzuki; Takahiro Maeda; Akiharu Ninomiya; So Nakamura
Journal:  Med Oncol       Date:  2013-06-25       Impact factor: 3.064

6.  The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers.

Authors:  Hideki Ujiie; Kyuichi Kadota; Jun-Ichi Nitadori; Joachim G Aerts; Kaitlin M Woo; Camelia S Sima; William D Travis; David R Jones; Lee M Krug; Prasad S Adusumilli
Journal:  Oncoimmunology       Date:  2015-03-19       Impact factor: 8.110

7.  Impact of academic affiliation on radical cystectomy outcomes in North America: A population-based study.

Authors:  Marco Bianchi; Quoc-Dien Trinh; Maxine Sun; Malek Meskawi; Jan Schmitges; Shahrokh F Shariat; Alberto Briganti; Zhe Tian; Claudio Jeldres; Shyam Sukumar; James O Peabody; Markus Graefen; Paul Perrotte; Mani Menon; Francesco Montorsi; Pierre I Karakiewicz
Journal:  Can Urol Assoc J       Date:  2012-08       Impact factor: 1.862

8.  Biostatistics: a toolkit for exploration, validation, and interpretation of clinical data.

Authors:  Jayawant N Mandrekar; Sumithra J Mandrekar
Journal:  J Thorac Oncol       Date:  2009-12       Impact factor: 15.609

9.  Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer.

Authors:  Justin D Blasberg; Harvey I Pass; Chandra M Goparaju; Raja M Flores; Suzie Lee; Jessica S Donington
Journal:  J Clin Oncol       Date:  2010-01-19       Impact factor: 44.544

10.  PrognoScan: a new database for meta-analysis of the prognostic value of genes.

Authors:  Hideaki Mizuno; Kunio Kitada; Kenta Nakai; Akinori Sarai
Journal:  BMC Med Genomics       Date:  2009-04-24       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.